A Practical Guide to Hot-Melt Extrusion Scale-Up for Pharmaceutical Applications

If action is not taken within 60 days, the White House said it would “deploy every tool in our arsenal” to improve drug pricing practices for American patients.

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

The authors performed interference and enhancement testing using a formulated alkaline and acid cleaner, as well as common biopharmaceutical process residues.

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

Re-Vana’s drug delivery technology is designed to release treatments over a 6- to 12-month period, with the goal of reducing frequency of injections for patients.

The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.